Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Gent

Showing results (111-120 of 242) with videos related to

Pageof 25
Sort By:
The New England Journal of Medicine|January 28, 1982
Adjusted subcutaneous heparin versus warfarin sodium in the long-term treatment of venous thrombosisR Hull, T Delmore, C Carter, et al.
The New England Journal of Medicine|October 18, 1979
Warfarin sodium versus low-dose heparin in the long-term treatment of venous thrombosisR Hull, T Delmore, E Genton, et al.
JAMA|May 3, 1976
Prevention of venous thrombosis with small, subcutaneous doses of heparinA S Gallus, J Hirsh, S E O'Brien, et al.
Annals of Internal Medicine|October 1, 1987
Adjusted subcutaneous heparin or continuous intravenous heparin in patients with acute deep vein thrombosis. A randomized trialD J Doyle, A G Turpie, J Hirsh, et al.
The Journal of Pediatrics|December 1, 1993
A prospective, randomized trial of high-dose intravenous immune globulin G therapy, oral prednisone therapy, and no therapy in childhood acute immune thrombocytopenic purpuraV S Blanchette, B Luke, M Andrew, et al.
Chest|April 1, 1990
Tissue plasminogen activator (rt-PA) vs heparin in deep vein thrombosis. Results of a randomized trialA G Turpie, M N Levine, J Hirsh, et al.
British Journal of Haematology|June 1, 1979
The influence of red blood cells on the effects of aspirin or sulphinpyrazone on platelet adherence to damaged rabbit aortaJ A Davies, E Essien, J P Cazenave, et al.
Thrombosis and Haemostasis|November 24, 1989
An evaluation of impedance plethysmography and 125I-fibrinogen leg scanning in patients following hip surgeryM K Cruickshank, M N Levine, J Hirsh, et al.
The New England Journal of Medicine|February 18, 1988
The thrombogenic effect of anticancer drug therapy in women with stage II breast cancerM N Levine, M Gent, J Hirsh, et al.
Australian and New Zealand Journal of Medicine|October 1, 1984
Lidocaine and the reduction of post-venographic painP A Ockelford, P J Powers, R D Hull, et al.
Pageof 25

Showing results (111-120 of 242) with videos related to

Sort By:
Pageof 25
The New England Journal of Medicine|January 28, 1982
Adjusted subcutaneous heparin versus warfarin sodium in the long-term treatment of venous thrombosisR Hull, T Delmore, C Carter, et al.
The New England Journal of Medicine|October 18, 1979
Warfarin sodium versus low-dose heparin in the long-term treatment of venous thrombosisR Hull, T Delmore, E Genton, et al.
JAMA|May 3, 1976
Prevention of venous thrombosis with small, subcutaneous doses of heparinA S Gallus, J Hirsh, S E O'Brien, et al.
Annals of Internal Medicine|October 1, 1987
Adjusted subcutaneous heparin or continuous intravenous heparin in patients with acute deep vein thrombosis. A randomized trialD J Doyle, A G Turpie, J Hirsh, et al.
The Journal of Pediatrics|December 1, 1993
A prospective, randomized trial of high-dose intravenous immune globulin G therapy, oral prednisone therapy, and no therapy in childhood acute immune thrombocytopenic purpuraV S Blanchette, B Luke, M Andrew, et al.
Chest|April 1, 1990
Tissue plasminogen activator (rt-PA) vs heparin in deep vein thrombosis. Results of a randomized trialA G Turpie, M N Levine, J Hirsh, et al.
British Journal of Haematology|June 1, 1979
The influence of red blood cells on the effects of aspirin or sulphinpyrazone on platelet adherence to damaged rabbit aortaJ A Davies, E Essien, J P Cazenave, et al.
Thrombosis and Haemostasis|November 24, 1989
An evaluation of impedance plethysmography and 125I-fibrinogen leg scanning in patients following hip surgeryM K Cruickshank, M N Levine, J Hirsh, et al.
The New England Journal of Medicine|February 18, 1988
The thrombogenic effect of anticancer drug therapy in women with stage II breast cancerM N Levine, M Gent, J Hirsh, et al.
Australian and New Zealand Journal of Medicine|October 1, 1984
Lidocaine and the reduction of post-venographic painP A Ockelford, P J Powers, R D Hull, et al.
Pageof 25